selected publications
- Specificity and functional humoral immune responses induced by the VBI-1501A eVLP HCMV gB vaccine compared to the gB/MF59 vaccine. Human vaccines & immunotherapeutics. 2025 Academic Article GET IT
-
Mammalian fatty acid synthase: a commonly used viral host dependency factor and a putative target for host-targeted broad-spectrum antiviral therapeutic development.
mBio.
2025
Information Resource
GET IT
Times cited: 3 -
A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.
Journal of virology.
2025
Academic Article
GET IT
Times cited: 4 -
Proceedings of the Conference "CMV Vaccine Development-How Close Are We?" (27-28 September 2023).
Vaccines.
2024
Conference Paper
GET IT
Times cited: 12 -
Research on Maternal Vaccination for HIV Prevention.
Clinics in perinatology.
2024
Information Resource
GET IT
Times cited: 1 -
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation.
Proceedings of the National Academy of Sciences of the United States of America.
2024
Academic Article
GET IT
Times cited: 19 -
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine.
The Journal of infectious diseases.
2024
Academic Article
GET IT
Times cited: 65 -
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus.
PLoS pathogens.
2023
Academic Article
GET IT
Times cited: 6 -
A bioorthogonal chemical reporter for fatty acid synthase-dependent protein acylation.
The Journal of biological chemistry.
2021
Academic Article
GET IT
Times cited: 11 -
Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections.
Frontiers in immunology.
2017
Information Resource
GET IT
Times cited: 260